Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

Down to Business Roundup Paper...

00:24:46

Down to Business Roundup Paper January 24th

Down To Business

00:24:46


Where does Ireland now stand i...

00:08:36

Where does Ireland now stand in the world when it comes to American relations?

Down To Business

00:08:36


Executive Chair: Jenny Johnsto...

00:12:04

Executive Chair: Jenny Johnston, CEO at Azure Communications

Down To Business

00:12:04


Industry Review: Business thro...

00:21:06

Industry Review: Business through the Irish language

Down To Business

00:21:06